Silver Book Fact

Between 2.7 and 6.1 million Americans have AFib.

AdvaMed. The Value of MedTech: To treat afib. Washington, D.C.: AdvaMed; 2015:1. https://www.advamed.org/sites/default/files/resource/963_afib_factsheet_9_2.pdf. Accessed November 9, 2015

Reference

Title
The Value of MedTech: To treat afib
Publisher
AdvaMed
Publication Date
2015
Authors
AdvaMed
Pages
1
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Atrial fibrillation as a contributory cause of death
    Around 84% of all deaths with atrial fibrillation as a contributory cause are in individuals age 75 and older.  
  • AFib rates by age
    Around 82% of Americans with atrial fibrillation are age 65 and older. Around 37% are age 80 and older.  
  • Healthcare costs of atrial fibrillation
    Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations…  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.